← Back to all trials
Not Yet Recruiting
NCT05648058
Role of Nefopam in Rituximab Transfusion Reaction
Conditions: Nefopam
Sex: All
Ages: 18 Years – 80 Years
Phase: PHASE3
Enrollment: 100
Sponsor: Ministry Of Health / Nineveh Health Directorate
Summary
the patients will be taken nefopam ampule 50 mg before rituximab in the first group while the second group will be taken diphenhydramine ampule 10 mg before rituximab in the second group
Eligibility Criteria
Inclusion Criteria:18 - 80 years old male and female will be taken rituximabExclusion Criteria:less than 18 years old more than 80 years old diabetic patients
Source: ClinicalTrials.gov (NCT05648058). StuddyBuddy aggregates publicly available trial information.
